ONCOLOGY
EUROPE’S MOST ADVANCED PRIVATE RADIOTHERAPY CENTRE The leading private provider of cancer services in the UK has opened Europe’s most advanced radiotherapy centre in London. GenesisCare is a modern healthcare provider that specialises in cancer care and is building a global network of treatment centres that is second to none. In the UK, GenesisCare has 14 outpatient oncology centres, including Oxford, Cambridge and Windsor. Now the company is bringing its unique cancer service to the heart of London’s medical district in a partnership with the prestigious Bupa Cromwell Hospital. The £20m flagship radiotherapy facility in Kensington has all the hallmarks of a GenesisCare treatment centre – equipped with the latest and most sophisticated technology and situated in a calm and uniquely patient centric healthcare environment.
62
When completed at the end of this year, it will house three of the world’s most advanced radiotherapy machines: the MRIdian MR-linac, the Gamma Knife Icon and the Varian Edge. The centre will specialise in neuro-oncology (cancers of brain and spine), complex and difficult-to-treat tumours in the abdomen and lung, as well as offering the latest techniques for common cancers, such as breast and prostate.
London’s latest cancer radiotherapy centre – and how it will meet the needs of patients from across Europe, Asia and the Middle East: “Our company ethos is to change the way people experience cancer treatment and care, understanding what it takes to achieve the best possible life outcomes and going further to provide it.
Patients will also have access to groundbreaking treatments available through the GenesisCare national network, including Theranostics, which uses radioactive drugs called radionuclides to seek out and destroy advanced metastatic cancers that have spread within the body.
"The GenesisCare global network is built on a simple business model – to offer fast access to world-class cancer care – and we invest early in new evidencebased modalities that hold potential for improved life outcomes. The strength of our relationships with oncologists is key to our success, enabling us to build a strong governance framework and to be the first to introduce many new cancer treatments safely and effectively.
James McArthur, General Manager UK, GenesisCare, explains the vision for
"In practice, this means advanced cancer techniques as standard, with
Groundbreaking treatments
